位置:首页 > 蛋白库 > NCAM1_MOUSE
NCAM1_MOUSE
ID   NCAM1_MOUSE             Reviewed;        1115 AA.
AC   P13595; P13594; Q61949; Q61950; Q6LBU8; Q8BQ96; Q8C4B2; Q921P2; Q9R2A7;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   22-JUL-2008, sequence version 3.
DT   03-AUG-2022, entry version 209.
DE   RecName: Full=Neural cell adhesion molecule 1;
DE            Short=N-CAM-1;
DE            Short=NCAM-1;
DE   AltName: CD_antigen=CD56;
DE   Flags: Precursor;
GN   Name=Ncam1; Synonyms=Ncam;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RC   STRAIN=C57BL/6J; TISSUE=Brain;
RX   PubMed=3595563; DOI=10.1002/j.1460-2075.1987.tb04837.x;
RA   Barthels D., Santoni M.-J., Wille W., Ruppert C., Chaix J.-C.,
RA   Hirsch M.-R., Fontecilla-Camps J.-C., Goridis C.;
RT   "Isolation and nucleotide sequence of mouse NCAM cDNA that codes for a Mr
RT   79,000 polypeptide without a membrane-spanning region.";
RL   EMBO J. 6:907-914(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   STRAIN=FVB/N; TISSUE=Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-1106 (ISOFORM 2).
RC   STRAIN=C57BL/6J; TISSUE=Cerebellum, and Spinal ganglion;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 20-700 AND 702-1115 (ISOFORMS 1 AND 2).
RC   STRAIN=C57BL/6J; TISSUE=Brain;
RX   PubMed=2721486; DOI=10.1002/j.1460-2075.1989.tb03389.x;
RA   Santoni M.J., Barthels D., Vopper G., Boned A., Goridis C., Wille W.;
RT   "Differential exon usage involving an unusual splicing mechanism generates
RT   at least eight types of NCAM cDNA in mouse brain.";
RL   EMBO J. 8:385-392(1989).
RN   [5]
RP   PROTEIN SEQUENCE OF 20-36.
RX   PubMed=3512556; DOI=10.1016/s0021-9258(17)35796-4;
RA   Rougon G., Marshak D.R.;
RT   "Structural and immunological characterization of the amino-terminal domain
RT   of mammalian neural cell adhesion molecules.";
RL   J. Biol. Chem. 261:3396-3401(1986).
RN   [6]
RP   PROTEIN SEQUENCE OF 38-48; 122-152; 166-177; 555-572; 584-595; 607-619;
RP   652-662 AND 685-691, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=C57BL/6J; TISSUE=Brain;
RA   Lubec G., Kang S.U.;
RL   Submitted (APR-2007) to UniProtKB.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 529-1115 (ISOFORM 2).
RC   STRAIN=C57BL/6J;
RX   PubMed=3684567; DOI=10.1093/nar/15.21.8621;
RA   Santoni M.-J., Barthels D., Barbas J.A., Hirsch M.-R., Steinmetz M.,
RA   Goridis C., Wille W.;
RT   "Analysis of cDNA clones that code for the transmembrane forms of the mouse
RT   neural cell adhesion molecule (NCAM) and are generated by alternative RNA
RT   splicing.";
RL   Nucleic Acids Res. 15:8621-8641(1987).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 642-1115.
RX   PubMed=3396534; DOI=10.1002/j.1460-2075.1988.tb02856.x;
RA   Barbas J.A., Chaix J.-C., Steinmetz M., Goridis C.;
RT   "Differential splicing and alternative polyadenylation generates distinct
RT   NCAM transcripts and proteins in the mouse.";
RL   EMBO J. 7:625-632(1988).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 804-1081 (ISOFORM 1).
RC   STRAIN=C57BL/6J; TISSUE=Brain;
RX   PubMed=2454455; DOI=10.1093/nar/16.10.4217;
RA   Barthels D., Vopper G., Wille W.;
RT   "NCAM-180, the large isoform of the neural cell adhesion molecule of the
RT   mouse, is encoded by an alternatively spliced transcript.";
RL   Nucleic Acids Res. 16:4217-4225(1988).
RN   [10]
RP   INTERACTION WITH MDK.
RX   PubMed=10772929; DOI=10.1006/bbrc.2000.2549;
RA   Muramatsu H., Zou K., Sakaguchi N., Ikematsu S., Sakuma S., Muramatsu T.;
RT   "LDL receptor-related protein as a component of the midkine receptor.";
RL   Biochem. Biophys. Res. Commun. 270:936-941(2000).
RN   [11]
RP   GLYCOSYLATION AT ASN-222; ASN-316; ASN-348; ASN-424; ASN-450 AND ASN-479,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain;
RX   PubMed=14658030; DOI=10.1007/s00216-003-2383-2;
RA   Albach C., Damoc E., Denzinger T., Schachner M., Przybylski M., Schmitz B.;
RT   "Identification of N-glycosylation sites of the murine neural cell adhesion
RT   molecule NCAM by MALDI-TOF and MALDI-FTICR mass spectrometry.";
RL   Anal. Bioanal. Chem. 378:1129-1135(2004).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-946; SER-958 AND SER-1005,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic brain;
RX   PubMed=15345747; DOI=10.1074/mcp.m400085-mcp200;
RA   Ballif B.A., Villen J., Beausoleil S.A., Schwartz D., Gygi S.P.;
RT   "Phosphoproteomic analysis of the developing mouse brain.";
RL   Mol. Cell. Proteomics 3:1093-1101(2004).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-774, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=16452087; DOI=10.1074/mcp.t500041-mcp200;
RA   Trinidad J.C., Specht C.G., Thalhammer A., Schoepfer R., Burlingame A.L.;
RT   "Comprehensive identification of phosphorylation sites in postsynaptic
RT   density preparations.";
RL   Mol. Cell. Proteomics 5:914-922(2006).
RN   [14]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-450.
RC   TISSUE=Myoblast;
RX   PubMed=19656770; DOI=10.1074/mcp.m900195-mcp200;
RA   Gundry R.L., Raginski K., Tarasova Y., Tchernyshyov I., Bausch-Fluck D.,
RA   Elliott S.T., Boheler K.R., Van Eyk J.E., Wollscheid B.;
RT   "The mouse C2C12 myoblast cell surface N-linked glycoproteome:
RT   identification, glycosite occupancy, and membrane orientation.";
RL   Mol. Cell. Proteomics 8:2555-2569(2009).
RN   [15]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-450.
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-linked
RT   cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-770; SER-774; SER-887;
RP   SER-890; SER-926; THR-929; SER-946; SER-958; THR-1001; SER-1005 AND
RP   THR-1030, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Heart, Kidney, and Spleen;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [17]
RP   STRUCTURE BY NMR OF 20-116, AND DISULFIDE BONDS.
RX   PubMed=8673600; DOI=10.1038/nsb0796-581;
RA   Thomsen N.K., Soroka V., Jensen P.H., Berezin V., Kiselyov V.V., Bock E.,
RA   Poulsen F.M.;
RT   "The three-dimensional structure of the first domain of neural cell
RT   adhesion molecule.";
RL   Nat. Struct. Biol. 3:581-585(1996).
RN   [18]
RP   STRUCTURE BY NMR OF 119-208, AND DISULFIDE BONDS.
RX   PubMed=10331878; DOI=10.1038/8292;
RA   Jensen P.H., Soroka V., Thomsen N.K., Ralets I., Berezin V., Bock E.,
RA   Poulsen F.M.;
RT   "Structure and interactions of NCAM modules 1 and 2, basic elements in
RT   neural cell adhesion.";
RL   Nat. Struct. Biol. 6:486-493(1999).
CC   -!- FUNCTION: This protein is a cell adhesion molecule involved in neuron-
CC       neuron adhesion, neurite fasciculation, outgrowth of neurites, etc.
CC   -!- SUBUNIT: Interacts with MDK. {ECO:0000269|PubMed:10772929}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Cell membrane; Single-pass type I
CC       membrane protein.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Cell membrane; Single-pass type I
CC       membrane protein.
CC   -!- SUBCELLULAR LOCATION: [Isoform 3]: Cell membrane; Lipid-anchor, GPI-
CC       anchor.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=N-CAM 180;
CC         IsoId=P13595-1; Sequence=Displayed;
CC       Name=2; Synonyms=N-CAM 140;
CC         IsoId=P13595-2; Sequence=VSP_002588;
CC       Name=3; Synonyms=N-CAM 120;
CC         IsoId=P13595-3, P13594-1;
CC         Sequence=VSP_034828, VSP_034829;
CC       Name=4;
CC         IsoId=P13595-4; Sequence=VSP_034826, VSP_034827;
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Y00051; CAA68263.1; -; mRNA.
DR   EMBL; BC011310; AAH11310.1; -; mRNA.
DR   EMBL; AK051197; BAC34554.2; -; mRNA.
DR   EMBL; AK082621; BAC38551.2; -; mRNA.
DR   EMBL; X15049; CAA33148.1; -; mRNA.
DR   EMBL; X15051; CAA33150.1; -; mRNA.
DR   EMBL; X15052; CAA33151.1; -; mRNA.
DR   EMBL; X06328; CAA29641.1; -; mRNA.
DR   EMBL; X07195; CAA30173.1; -; Genomic_DNA.
DR   EMBL; X07197; CAA30175.1; -; Genomic_DNA.
DR   EMBL; X07198; CAB40820.1; -; Genomic_DNA.
DR   EMBL; X07200; CAA30177.1; -; Genomic_DNA.
DR   EMBL; X07244; CAA30230.1; -; mRNA.
DR   CCDS; CCDS40617.1; -. [P13595-2]
DR   CCDS; CCDS40618.1; -. [P13595-3]
DR   PIR; A29673; IJMSNL.
DR   RefSeq; NP_001074914.1; NM_001081445.1.
DR   RefSeq; NP_001106675.1; NM_001113204.1.
DR   RefSeq; NP_001297994.1; NM_001311065.1.
DR   RefSeq; NP_035005.2; NM_010875.3.
DR   PDB; 2NCM; NMR; -; A=20-116.
DR   PDB; 3NCM; NMR; -; A=119-208.
DR   PDBsum; 2NCM; -.
DR   PDBsum; 3NCM; -.
DR   AlphaFoldDB; P13595; -.
DR   BMRB; P13595; -.
DR   SMR; P13595; -.
DR   BioGRID; 201699; 19.
DR   CORUM; P13595; -.
DR   IntAct; P13595; 7.
DR   MINT; P13595; -.
DR   STRING; 10090.ENSMUSP00000130668; -.
DR   GlyConnect; 2535; 6 N-Linked glycans (3 sites).
DR   GlyGen; P13595; 6 sites, 6 N-linked glycans (3 sites).
DR   iPTMnet; P13595; -.
DR   PhosphoSitePlus; P13595; -.
DR   SwissPalm; P13595; -.
DR   CPTAC; non-CPTAC-3846; -.
DR   jPOST; P13595; -.
DR   MaxQB; P13595; -.
DR   PaxDb; P13595; -.
DR   PeptideAtlas; P13595; -.
DR   PRIDE; P13595; -.
DR   ProteomicsDB; 287445; -. [P13595-1]
DR   ProteomicsDB; 287446; -. [P13595-2]
DR   ProteomicsDB; 287447; -. [P13595-3]
DR   ProteomicsDB; 287448; -. [P13595-4]
DR   DNASU; 17967; -.
DR   GeneID; 17967; -.
DR   KEGG; mmu:17967; -.
DR   UCSC; uc009pje.2; mouse. [P13595-1]
DR   CTD; 4684; -.
DR   MGI; MGI:97281; Ncam1.
DR   eggNOG; KOG3510; Eukaryota.
DR   InParanoid; P13595; -.
DR   OrthoDB; 129648at2759; -.
DR   PhylomeDB; P13595; -.
DR   Reactome; R-MMU-375165; NCAM signaling for neurite out-growth.
DR   Reactome; R-MMU-419037; NCAM1 interactions.
DR   Reactome; R-MMU-445144; Signal transduction by L1.
DR   Reactome; R-MMU-5673001; RAF/MAP kinase cascade.
DR   BioGRID-ORCS; 17967; 1 hit in 73 CRISPR screens.
DR   ChiTaRS; Ncam1; mouse.
DR   EvolutionaryTrace; P13595; -.
DR   PRO; PR:P13595; -.
DR   Proteomes; UP000000589; Unplaced.
DR   RNAct; P13595; protein.
DR   GO; GO:0031225; C:anchored component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0030424; C:axon; IDA:MGI.
DR   GO; GO:0009986; C:cell surface; ISO:MGI.
DR   GO; GO:0005911; C:cell-cell junction; IDA:MGI.
DR   GO; GO:0005829; C:cytosol; ISO:MGI.
DR   GO; GO:0009897; C:external side of plasma membrane; IDA:MGI.
DR   GO; GO:0098978; C:glutamatergic synapse; ISO:MGI.
DR   GO; GO:0030426; C:growth cone; IDA:MGI.
DR   GO; GO:0099055; C:integral component of postsynaptic membrane; ISO:MGI.
DR   GO; GO:0099056; C:integral component of presynaptic membrane; ISO:MGI.
DR   GO; GO:0043209; C:myelin sheath; HDA:UniProtKB.
DR   GO; GO:0043005; C:neuron projection; IBA:GO_Central.
DR   GO; GO:0043025; C:neuronal cell body; IDA:MGI.
DR   GO; GO:0005886; C:plasma membrane; ISO:MGI.
DR   GO; GO:0098685; C:Schaffer collateral - CA1 synapse; ISO:MGI.
DR   GO; GO:0008201; F:heparin binding; IEA:UniProtKB-KW.
DR   GO; GO:0030275; F:LRR domain binding; ISO:MGI.
DR   GO; GO:0019902; F:phosphatase binding; ISO:MGI.
DR   GO; GO:0007568; P:aging; ISO:MGI.
DR   GO; GO:0007413; P:axonal fasciculation; ISO:MGI.
DR   GO; GO:0019722; P:calcium-mediated signaling; IDA:MGI.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; IDA:MGI.
DR   GO; GO:0071679; P:commissural neuron axon guidance; IGI:ARUK-UCL.
DR   GO; GO:0034109; P:homotypic cell-cell adhesion; IMP:MGI.
DR   GO; GO:0007611; P:learning or memory; ISO:MGI.
DR   GO; GO:0050804; P:modulation of chemical synaptic transmission; ISO:MGI.
DR   GO; GO:0033555; P:multicellular organismal response to stress; ISO:MGI.
DR   GO; GO:0060548; P:negative regulation of cell death; ISO:MGI.
DR   GO; GO:0048666; P:neuron development; ISO:MGI.
DR   GO; GO:0031175; P:neuron projection development; IGI:MGI.
DR   GO; GO:0050850; P:positive regulation of calcium-mediated signaling; IDA:MGI.
DR   GO; GO:0060045; P:positive regulation of cardiac muscle cell proliferation; ISO:MGI.
DR   GO; GO:0001928; P:regulation of exocyst assembly; IMP:MGI.
DR   GO; GO:2001260; P:regulation of semaphorin-plexin signaling pathway; IGI:ARUK-UCL.
DR   GO; GO:0051930; P:regulation of sensory perception of pain; ISO:MGI.
DR   GO; GO:0042220; P:response to cocaine; ISO:MGI.
DR   GO; GO:0010288; P:response to lead ion; ISO:MGI.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; ISO:MGI.
DR   GO; GO:0021794; P:thalamus development; ISO:MGI.
DR   CDD; cd00063; FN3; 2.
DR   Gene3D; 2.60.40.10; -; 7.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR013106; Ig_V-set.
DR   InterPro; IPR033019; Ncam1.
DR   InterPro; IPR009138; Neural_cell_adh.
DR   PANTHER; PTHR12231:SF239; PTHR12231:SF239; 1.
DR   Pfam; PF00041; fn3; 2.
DR   Pfam; PF07679; I-set; 3.
DR   PRINTS; PR01838; NCAMFAMILY.
DR   SMART; SM00060; FN3; 2.
DR   SMART; SM00409; IG; 5.
DR   SMART; SM00408; IGc2; 5.
DR   SMART; SM00406; IGv; 2.
DR   SUPFAM; SSF48726; SSF48726; 5.
DR   SUPFAM; SSF49265; SSF49265; 1.
DR   PROSITE; PS50853; FN3; 2.
DR   PROSITE; PS50835; IG_LIKE; 5.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell adhesion; Cell membrane;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein; GPI-anchor;
KW   Heparin-binding; Immunoglobulin domain; Lipoprotein; Membrane;
KW   Phosphoprotein; Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..19
FT                   /evidence="ECO:0000269|PubMed:3512556"
FT   CHAIN           20..1115
FT                   /note="Neural cell adhesion molecule 1"
FT                   /id="PRO_0000015012"
FT   TOPO_DOM        20..711
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        712..729
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        730..1115
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          20..111
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          116..205
FT                   /note="Ig-like C2-type 2"
FT   DOMAIN          212..302
FT                   /note="Ig-like C2-type 3"
FT   DOMAIN          309..402
FT                   /note="Ig-like C2-type 4"
FT   DOMAIN          407..492
FT                   /note="Ig-like C2-type 5"
FT   DOMAIN          500..599
FT                   /note="Fibronectin type-III 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          601..696
FT                   /note="Fibronectin type-III 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   REGION          756..809
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          839..912
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          924..1115
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        757..798
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        839..891
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1006..1020
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1078..1092
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         152..156
FT                   /ligand="heparin"
FT                   /ligand_id="ChEBI:CHEBI:28304"
FT                   /evidence="ECO:0000255"
FT   BINDING         161..165
FT                   /ligand="heparin"
FT                   /ligand_id="ChEBI:CHEBI:28304"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         770
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         774
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16452087,
FT                   ECO:0007744|PubMed:21183079"
FT   MOD_RES         887
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         890
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         926
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         929
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         946
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:15345747,
FT                   ECO:0007744|PubMed:21183079"
FT   MOD_RES         958
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:15345747,
FT                   ECO:0007744|PubMed:21183079"
FT   MOD_RES         1001
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         1005
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:15345747,
FT                   ECO:0007744|PubMed:21183079"
FT   MOD_RES         1030
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   CARBOHYD        222
FT                   /note="N-linked (GlcNAc...) asparagine; partial"
FT                   /evidence="ECO:0000269|PubMed:14658030"
FT   CARBOHYD        316
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:14658030"
FT   CARBOHYD        348
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:14658030"
FT   CARBOHYD        424
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:14658030"
FT   CARBOHYD        450
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:14658030,
FT                   ECO:0000269|PubMed:19349973, ECO:0000269|PubMed:19656770"
FT   CARBOHYD        479
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:14658030"
FT   DISULFID        41..96
FT                   /evidence="ECO:0000269|PubMed:8673600,
FT                   ECO:0007744|PDB:2NCM"
FT   DISULFID        139..189
FT                   /evidence="ECO:0000269|PubMed:10331878,
FT                   ECO:0007744|PDB:3NCM"
FT   DISULFID        235..288
FT                   /evidence="ECO:0000305"
FT   DISULFID        330..386
FT                   /evidence="ECO:0000305"
FT   DISULFID        427..480
FT                   /evidence="ECO:0000305"
FT   VAR_SEQ         601..605
FT                   /note="EPSAP -> KSSLF (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_034826"
FT   VAR_SEQ         606..1115
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_034827"
FT   VAR_SEQ         702..725
FT                   /note="NGSPTAGLSTGAIVGILIVIFVLL -> TLGGSSTSYTLVSLLFSAVTLLLL
FT                   (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:3595563"
FT                   /id="VSP_034828"
FT   VAR_SEQ         726..1115
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:3595563"
FT                   /id="VSP_034829"
FT   VAR_SEQ         810..1076
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16141072,
FT                   ECO:0000303|PubMed:2721486, ECO:0000303|PubMed:3684567"
FT                   /id="VSP_002588"
FT   CONFLICT        20
FT                   /note="L -> M (in Ref. 4; CAA33148)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        158
FT                   /note="V -> F (in Ref. 2; AAH11310)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        261..268
FT                   /note="DEKHIFSD -> ERSRSSVS (in Ref. 1; CAA68263)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        273
FT                   /note="L -> V (in Ref. 1; CAA68263)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        354..355
FT                   /note="KT -> QD (in Ref. 1; CAA68263)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        379
FT                   /note="T -> R (in Ref. 1; CAA68263 and 4; CAA33148)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        385
FT                   /note="I -> M (in Ref. 1; CAA68263 and 4; CAA33148)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        399..400
FT                   /note="MY -> ID (in Ref. 1; CAA68263 and 4; CAA33148)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        403
FT                   /note="F -> V (in Ref. 2; AAH11310 and 3; BAC34554/
FT                   BAC38551)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        549
FT                   /note="K -> T (in Ref. 1; CAA68263)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        572
FT                   /note="R -> T (in Ref. 1; CAA68263)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        575
FT                   /note="V -> D (in Ref. 1; CAA68263)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        589..594
FT                   /note="SAATEF -> MQPSES (in Ref. 1; CAA68263)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        600..602
FT                   /note="REP -> PEL (in Ref. 1; CAA68263)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        657
FT                   /note="D -> H (in Ref. 1; CAA68263)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        733
FT                   /note="C -> W (in Ref. 3; BAC34554)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1082
FT                   /note="T -> A (in Ref. 3; BAC34554)"
FT                   /evidence="ECO:0000305"
FT   STRAND          21..32
FT                   /evidence="ECO:0007829|PDB:2NCM"
FT   STRAND          37..44
FT                   /evidence="ECO:0007829|PDB:2NCM"
FT   STRAND          47..49
FT                   /evidence="ECO:0007829|PDB:2NCM"
FT   STRAND          51..56
FT                   /evidence="ECO:0007829|PDB:2NCM"
FT   TURN            57..59
FT                   /evidence="ECO:0007829|PDB:2NCM"
FT   STRAND          64..73
FT                   /evidence="ECO:0007829|PDB:2NCM"
FT   STRAND          75..77
FT                   /evidence="ECO:0007829|PDB:2NCM"
FT   STRAND          79..85
FT                   /evidence="ECO:0007829|PDB:2NCM"
FT   TURN            88..90
FT                   /evidence="ECO:0007829|PDB:2NCM"
FT   STRAND          92..99
FT                   /evidence="ECO:0007829|PDB:2NCM"
FT   STRAND          101..103
FT                   /evidence="ECO:0007829|PDB:2NCM"
FT   STRAND          105..115
FT                   /evidence="ECO:0007829|PDB:2NCM"
FT   STRAND          119..122
FT                   /evidence="ECO:0007829|PDB:3NCM"
FT   STRAND          125..128
FT                   /evidence="ECO:0007829|PDB:3NCM"
FT   STRAND          133..137
FT                   /evidence="ECO:0007829|PDB:3NCM"
FT   STRAND          140..143
FT                   /evidence="ECO:0007829|PDB:3NCM"
FT   STRAND          145..157
FT                   /evidence="ECO:0007829|PDB:3NCM"
FT   HELIX           158..161
FT                   /evidence="ECO:0007829|PDB:3NCM"
FT   STRAND          166..168
FT                   /evidence="ECO:0007829|PDB:3NCM"
FT   STRAND          174..178
FT                   /evidence="ECO:0007829|PDB:3NCM"
FT   STRAND          185..193
FT                   /evidence="ECO:0007829|PDB:3NCM"
FT   TURN            194..197
FT                   /evidence="ECO:0007829|PDB:3NCM"
FT   STRAND          198..207
FT                   /evidence="ECO:0007829|PDB:3NCM"
FT   LIPID           P13595-3:706
FT                   /note="GPI-anchor amidated serine"
FT                   /evidence="ECO:0000255"
SQ   SEQUENCE   1115 AA;  119427 MW;  78AF831BABD23918 CRC64;
     MLRTKDLIWT LFFLGTAVSL QVDIVPSQGE ISVGESKFFL CQVAGDAKDK DISWFSPNGE
     KLSPNQQRIS VVWNDDDSST LTIYNANIDD AGIYKCVVTA EDGTQSEATV NVKIFQKLMF
     KNAPTPQEFK EGEDAVIVCD VVSSLPPTII WKHKGRDVIL KKDVRFIVLS NNYLQIRGIK
     KTDEGTYRCE GRILARGEIN FKDIQVIVNV PPTVQARQSI VNATANLGQS VTLVCDADGF
     PEPTMSWTKD GEPIENEEED DEKHIFSDDS SELTIRNVDK NDEAEYVCIA ENKAGEQDAS
     IHLKVFAKPK ITYVENQTAM ELEEQVTLTC EASGDPIPSI TWRTSTRNIS SEEKTLDGHM
     VVRSHARVSS LTLKSIQYTD AGEYICTASN TIGQDSQSMY LEFQYAPKLQ GPVAVYTWEG
     NQVNITCEVF AYPSATISWF RDGQLLPSSN YSNIKIYNTP SASYLEVTPD SENDFGNYNC
     TAVNRIGQES LEFILVQADT PSSPSIDRVE PYSSTAQVQF DEPEATGGVP ILKYKAEWKS
     LGEESWHFKW YDAKEANMEG IVTIMGLKPE TRYSVRLAAL NGKGLGEISA ATEFKTQPVR
     EPSAPKLEGQ MGEDGNSIKV NLIKQDDGGS PIRHYLVKYR ALASEWKPEI RLPSGSDHVM
     LKSLDWNAEY EVYVVAENQQ GKSKAAHFVF RTSAQPTAIP ANGSPTAGLS TGAIVGILIV
     IFVLLLVVMD ITCYFLNKCG LLMCIAVNLC GKAGPGAKGK DMEEGKAAFS KDESKEPIVE
     VRTEEERTPN HDGGKHTEPN ETTPLTEPEL PADTTATVED MLPSVTTVTT NSDTITETFA
     TAQNSPTSET TTLTSSIAPP ATTVPDSNSV PAGQATPSKG VTASSSSPAS APKVAPLVDL
     SDTPTSAPSA SNLSSTVLAN QGAVLSPSTP ASAGETSKAP PASKASPAPT PTPAGAASPL
     AAVAAPATDA PQAKQEAPST KGPDPEPTQP GTVKNPPEAA TAPASPKSKA ATTNPSQGED
     LKMDEGNFKT PDIDLAKDVF AALGSPRPAT GASGQASELA PSPADSAVPP APAKTEKGPV
     ETKSEPPESE AKPAPTEVKT VPNDATQTKE NESKA
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024